FDA approves first vaccine against respiratory syncytial virus
The US Food and Drug Administration (FDA) has approved GlaxoSmithKline’s Arexvy vaccine, making it the first approved vaccine for respiratory syncytial virus (RSV) in the world. RSV causes mild symptoms…